Colombo, Sri Lanka

13-24 October 2024

This seminar is primarily aimed at young physicians and scientists working in the field of cardiovascular disease. The original aim of the founders Professors Jerry Stamler from the US and Professor Geoffrey Rose from UK was global leadership capacity building and fostering international research and public health networks.  The success of this seminar is evidenced by the alumni who are now international leaders in cardiovascular disease research and prevention activities who have had major impact in transforming clinical practice and health in the population.  The seminar is held in a different country each year to encourage regional participation and used as an opportunity, often with the local ministry of health or university, to raise awareness of the importance of cardiovascular disease prevention and encourage relevant research and policy.

 Saint-Petersburg, 26-28 September 2024

High-Level Conference on Cardiovascular Health: Addressing the EU’s biggest killer

in ESC

The world’s leading event on heart failure

It covers the entire spectrum of heart failure, from prevention to diagnosis and treatment.

Heart Failure Congress is the annual congress of the Heart Failure Association of the ESC.

Chairpersons

Fausto Jose Pinto (Santa Maria Hospital – CHULN – Lisbon, Portugal)  fjpinto1960Roberto Ferrari (University of Ferrara – Ferrara, Italy)

Presentations

A phase 2b, randomised, double-blind, active controlled, multi centre study to evaluate the efficacy, safety and tolerability of oral AZD9977 and dapagliflozin treatment in patients with heart failure Speaker: Carolyn Sp Lam (Duke-NUS Graduate Medical School Singapore – Singapore, Singapore)  lamcardio Time: 13:45

Discussant review – MIRACLE Speaker: Milton Packer (Baylor University Medical Center – Dallas, United States of America) Time: 13:53

A phase 2, randomized, double-blind, placebo-controlled study to assess the tolerability and pharmacodynamic effects of CRD-740, a PDE9 inhibitor, in participants with chronic heart failure Speaker: James E Udelson (Tufts Medical Center, Inc. – Boston, United States of America)  EduGuasch Time: 13:57

Discussant review – CARDINAL HF Speaker: Allan Bohm (Premedix & Seerlinq – Bratislava, Slovakia)  SorinS_Popescu Time: 14:05

Readily available urinary sodium analysis in patients with acute decompensate Heart Failure Speaker: Evelyne Meekers (Hospital Oost-Limburg (ZOL) – Genk, Belgium)  CzechCardio Time: 14:09

Discussant review – EASY-HF Speaker: Pierpaolo Pellicori (University of Glasgow – Glasgow, United Kingdom of Great Britain & Northern Ireland)  PierpaoloPel Time: 14:17

DEA-HF: The heart failure diuresis efficacy comparison study Speaker: Aharon Abbo (Rambam Health Care Campus – Haifa, Israel)  Ronnie_A Time: 14:21

Discussant review – DEA-HF Speaker: Kevin Damman (University Medical Centre Groningen – Groningen, Netherlands (The))  kevin_damman Time: 14:29

Low-dose administration of carperitide for Acute Heart Failure Speaker: Toshiyuki Nagai (Hokkaido University – Sapporo, Japan) Time: 14:33

Discussant review – LASCAR-AHF Speaker: Lars Lund (Karolinska University Hospital – Stockholm, Sweden) Time: 14:41

Conheça a equipa de moderação do evento “𝐓𝐡𝐞 𝐒𝐭𝐞𝐩𝐩𝐢𝐧𝐠 𝐬𝐭𝐨𝐧𝐞 𝐭𝐨 𝐂𝐥𝐢𝐧𝐢𝐜𝐚𝐥 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡”, do dia 17 de abril, das 09h00 às 12h30 na Faculdade de Medicina da Universidade de Lisboa.

Erice, 21st to 24th March, 2024

Organised by  Professor Salvatore Novo co-Director of the International School of Cardiology at the “Ettore Majorana” Foundation & Centre for Scientific Culture di Erice, togeteher with Professor Francesco Fedele (Rome), I organize the XXIV Workshop on “Advances in Cardiovascular Diseases and Therapy“

Este Congresso visa, em primeiro lugar, promover a discussão aberta sobre novas fronteiras no que tem sido uma evolução fascinante no âmbito do diagnóstico e terapêutica cardiovascular. Nele participam um vasto número de peritos nacionais e estrangeiros, constituindo uma excelente oportunidade de formação pós-graduada na área da Medicina Cardiovascular.

Em resultado do significativo crescimento verificado em edições anteriores, iremos retomar o formato de duas salas de sessões plenárias em simultâneo. Os conferencistas podem circular livremente entre ambas as salas plenárias.

Os três dias do Congresso decorrerão exclusivamente no centro de conferências.

Sendo uma reunião primariamente destinada aos profissionais de saúde que lidam diariamente e mais intensamente com problemas cardiovasculares, pretende-se, contudo, estender o seu âmbito aos profissionais cuja área de intervenção abrange necessariamente as doenças cardiovasculares, como sejam, internistas, intensivistas, cirurgiões, médicos de família, enfermeiros e técnicos.

Contamos com a sua participação ativa para ajudar a criar um ambiente dinâmico de interação e troca de experiências. Ao mesmo tempo esta é também uma oportunidade de mostrar um pouco sobre alguns dos múltiplos projetos de investigação e através da interação com colegas de outros centros, podermos lançar novas ideias.

Estamos confiantes de que esta reunião representa um ponto de encontro de colegas que partilham os mesmos problemas e preocupações, aproveitando o envolvente desta região para momentos de reflexão num ambiente a isso propício.

February 2 and 3, 2024

12 de Janeiro 2024

O CIRCE é um encontro científico com foco nos mais recentes avanços ciêntificos na doença cardiovascular. Este ano, o CIRCE será presidido pela Professora Carolyn Lam e irá contar com um painel de peritos globais.

A agenda final ainda não está fechada sendo que será partilhada durante o mês de Agosto, mas anexo o teaser oficial do CIRCE sendo que o foco da reunião será nos seguintes tópicos:

• Dados mais recentes na doença cardiovascular incluíndo os ensaios clinicos SELECT e STEP-HFpEF

• Otimização dos eventos cardiovasculares em pacientes com DMT2 e obesidade, o mecanismo de ação dos agonistas da GLP-1 na doença cardiovascular e doença arterial periférica

• Insuficiência cardíaca (HFpEF, o fenótipo de obesidade da HFpEF e ATTR-CM como uma causa sub-reconhecida de HFpEF)

• O papel da inflamação sistémica na doença aterosclerótica e no enfarte agudo do miocárdio

SELECT was a randomised, double-blind, parallel-group, placebo-controlled trial designed to evaluate the efficacy of semaglutide 2.4 mg versus placebo as an adjunct to standard of care for prevention of MACE in people with established CVD with overweight or obesity with no prior history of diabetes. People included in the trial were aged ≥45 years with a BMI ≥27 kg/m².

The primary objective of the SELECT trial was to demonstrate superiority of semaglutide 2.4 mg compared to placebo with respect to reducing the incidence of three-point MACE consisting of cardiovascular death, non-fatal myocardial infarction or non-fatal stroke. Key secondary objectives were to compare the effects of semaglutide 2.4 mg to placebo with regards to mortality, cardiovascular risk factors, glucose metabolism, body weight and renal function.

The trial enrolled 17,604 adults and has been conducted in 41 countries at more than 800 investigator sites. The SELECT trial was initiated in 2018.

SISMED ^ETS, SOCIETÀ ITALIANA SCIENZE MEDICHE ^ETS, È UN’ASSOCIAZIONE MEDICO-SCIENTIFICA MULTIDISCIPLINARE I CUI SCOPI PRINCIPALI SONO PROMUOVERE L’AGGIORNAMENTO PROFESSIONALE, CULTURALE, TECNOLOGICO E STRUMENTALE DEI PROPRI ISCRITTI ATTRAVERSO TUTTE LE ATTIVITÀ ATTE A TALE SCOPO, SOSTENERE L’ATTIVITÀ DI AGGIORNAMENTO PROFESSIONALE E LO SCAMBIO DI CONOSCENZE INTERDISCIPLINARI TRA LE VARIE BRANCHE MEDICHE.

NAPOLI, 1-3 Dicembre 2023, Hotel Royal Continental. Il tema centrale del nostro congresso è la “Complessità Clinica”, un concetto che definisce il panorama medico odierno. Con le patologie sempre più emergenti, l’aumento dell’aspettativa di vita e l’evoluzione delle terapie, la medicina si trova di fronte a sfide sempre più intricate. Ecco quindi perché diventa cruciale esplorare, condividere e affrontare insieme questa complessità.

28th & 29th NOVEMBER 2023

ORGANIZED BY:
Cardiology University of Messina
Residential school in cardiovascular diseases, University of Messina

The main objective of the Congress will be to provide an appropriate scientific updating on major cardiovascular diseases such as heart failure, ischemic heart disease, valvular disease, cardiomyopathies, arrhythmias, cardio-oncology. One session will be dedicated to the role of imaging in the field of the important cardiovascular diseases. The program also includes some lectures on emerging issues The topics to be addressed and the quality of the international and national speakers is a guarantee of the high scientific profile and the good result of the congress.

24-25.11.2023 Sofia, Bulgaria

November 22 – 24, 2023 – ICRC FNUSA, Brno, Czech Republic

Dhaka, 16-17 November 2023

A Conferência Gender Mainstreaming in Medicine and Medical Research decorre no âmbito do projeto ERA Chair iSTARS – Informatics and Statistical Tools for the Advancement of Research Success, promovido pela Faculdade de Medicina da Universidade de Lisboa e financiado pela União Europeia (Projeto 952377).

A organização do evento está a cargo da Faculdade de Medicina da ULisboa em parceria com o Centro Interdisciplinar de Estudos de Género (CIEG/ISCSP-ULisboa).

Dirigido a médicos/as, investigadores/as e estudantes, bem como a todos/as os/as interessados/as em aplicar a perspetiva do género na medicina e na investigação médica, o evento terá como keynote speaker a neurocientista e Professora Emérita da Aston University, Gina Rippon.

O Curso Pós-Graduado de Atualização em Cardio-Oncologia, promovido pela FMUL, realizar-se-á nos dias 16 e 17 de março, no Edifício Egas Moniz.

Num formato híbrido a formação será presencial, contudo e devido às ligações à ICOS, o curso contará com nomes de elevada referência do panorama internacional e que vêm assim enriquecer mais ainda esta formação que tem revelado grande sucesso e procura.

Joint Strategic & Global Expert Panel Meeting, 15 March 2023, Baveno, Italy

ZEUS trial with ziltivekimab aims to validate the link between hsCRP and major adverse cardiovascular events

March 4-6, 2023

ACC.23/WCC is packed from beginning to end with 300+ sessions taking place over the course of 3 days and 80+ session live-streaming around the world.

ALTERAÇÕES CLIMÁTICAS, POLUIÇÃO E DOENÇA CARDIOVASCULAR

Call to Action

11-22 December 2022, Kochi ,India

The International Society of Cardiovascular Disease Epidemiology and Prevention, in collaboration with the World Heart Federation, announces the 52nd Ten-Day International Teaching Seminar on Cardiovascular Disease Epidemiology and Prevention to be held from December 11-22, 2022 in Kochi, India. The seminar is co-hosted by Prof. Krishna Kumar, Amrita Institute of Medical Sciences and Centre, Kochi and Prof. Dorairaj Prabhakaran, Executive Director, Centre for Chronic Disease Control, New Delhi India. Approximately 36 Fellows can be accepted. The final selection will be made by the Society’s Seminar Committee. Nominees should normally be at the postgraduate level with residency training or its equivalent, and be interested in cardiovascular disease epidemiology. Normally, preference will be given to younger candidates, with little or no formal training in epidemiology. Tuition, board and accommodation are provided without cost to fellows. Fellows and their sponsors are responsible for their own travel costs to the seminar. COVID-19 vaccination is a requirement for attendance.

CVCT is an unique think tank, experts only forum aiming at discussing important and timely CV trials and trial science issues (design, methodology, interpretation, approval and implementation). Emphasis is on interaction among highly knowledgeable experts, with as little lecturing as possible, and as much think-tank interaction as possible.

CVCT is also unique in that it assembles key global experts from multiple backgrounds, including academy, industry R&D, regulatory agencies (FDA, EMA), major journal editors, NHLBI, payers (CMS, HTA organisations) and patient representatives. CVCT enjoys support from and partnership with major learned societies in the field.

Context

Over the past 50 years, European countries have seen consistent growth in life expectancy, largely due to improvements in the management of cardiovascular disease (CVD). But this progress has stalled, and the number of people dying from CVD is steadily rising. This is a serious concern for the future of our societies and health systems.

CVD takes a huge toll on people’s lives and costs European countries billions of euros. CVD is Europe’s leading cause of death, accounting for 45% of all deaths in 2017. But a high proportion of these are preventable, either through addressing modifiable risk factors or improving access to high-quality care and disease management.

If we know how to prevent and manage CVD, why aren’t we doing it? There is no easy answer, but it is telling that despite the huge structural barriers to securing consistent guideline-based cardiovascular care for all who need it, political awareness of CVD appears to be low. Many national plans and strategies in this area are outdated, or lack concrete investment and implementation measures.

There have recently been signs of renewed interest in CVD. The COVID-19 pandemic has taken a huge toll on front-line care services, but has also been a wake-up call for governments to reconsider the resilience and sustainability of our health systems. We urgently need greater clarity as to what effective CVD policies might look like.

SPEAKERS

• Birgit Beger CEO of the European Heart Network
• James Kennedy Director of Public Affairs European Society of Cardiology
• Dr Jane Barratt Secretary General of the International Federation on Ageing
• Professor Larry Sperling of the Emory University School of Medicine, United States
• Professor Huon Grey, former National Clinical Director for Heart Disease, NHS England
• Dr. Anneke Schmider, Chatham House Fellow, formerly WHO and Treasury of the Queensland Government, Australia
• Neil Johnson, National Institute for Prevention and Cardiovascular Health, Ireland

At this launch, we seek to bring original insights into how we can progress a new generation of national CVD plans, while simultaneously securing deeper political commitment to them from a wider spectrum of societal and economic agendas. This reflects the content of two new think pieces we’ve produced, which are Finding inspiration within prominent national cardiovascular disease plans (July 2022), and The heart of society – why addressing cardiovascular disease is critical to achieving wider societal goals (Sept 2022)

17 e 18 de novembro de 2022 | Centro Ismaili de Lisboa

The Heart Failure Policy Summit is the only dedicated policy event for the heart failure community in Europe.

It provides a much-needed forum for collaboration and discussion between patient advocates from different sectors. The Summit aims to elevate the efforts of national-level heart failure advocates to engage decision-makers and policymakers across Europe. It supports members of our community to form relationships and learn from one another’s experiences.

Each session features experts from the heart failure and wider health advocacy communities, including high-profile clinical leaders and experienced patient advocates. We will also be joined by policymakers, past and present, who will share their perspectives on the current policy environment and opportunities for change.

Heart failure, inequality and the world stage: connecting advocates with the global policy agenda

Policymakers are increasingly conscious of issues faced by people from minority communities, women and marginalised populations. Now is the time to share knowledge and experience of the stark inequalities affecting people with heart failure. How can advocates tap into global policy agendas, activate policymakers, and create solutions to reduce the burden of heart failure among all population groups in an equitable way?

Chair: Ed Harding, Network Director, Heart Failure Policy Network

Featuring:

• Professor Amitava Banerjee, Professor of Clinical Data Science, Institute of Health Informatics, University College London
• Dr Nathalie Conrad, Marie Skłodowska-Curie fellow, Leuven University
• Professor Martha Gulati, President-Elect, American Society for Preventive Cardiology
• Professor Fausto Pinto, President, World Heart Federation
• Dr Antonia Sambola, Coordinator, Working Group Women in Cardiology, Spanish Society of Cardiology
• Aistė Štaraitė, Heart Failure Development Executive & Chair, Global Heart Hub Heart Failure Patient Council
• Anne Wray, Advanced Nurse Practitioner, Bristol Inner City Primary Care Network

Organizado por: HOSPITAL ALEMÃO OSWALDO CRUZ

Data: Sexta, 28 de outubro 2022, 13h30

Local: Hospital Alemão Oswaldo Cruz , São Paulo, SP

Kenya Cardiac Society

The meeting will bring together various stakeholders including the Ministry of Health, World Health Organization, NCD Alliance of Kenya, Neurological Society, patient-led organizations (Stroke Association of Kenya – SOAK) and implementing partners.

The purpose of this talk is to showcase the impact of the WHF Roundtable meetings in driving local action to improve CVD care. We will be happy to get your input on the proposed topic.

A Sessão Solene de Abertura do Ano Académico 2022/2023 decorre no dia 6 de outubro na Aula Magna da Universidade de Lisboa (ULisboa).

Celebrando o início de um novo Ano Académico, esta sessão solene é um importante marco na vida académica da ULisboa e junta toda a sua Comunidade.

PROGRAMA

15h30 Abertura da Sessão

• Intervenção do Estudante – Gonçalo Mamede
• Intervenção do Trabalhador Técnico Administrativo – Dr. Carlos Dá Mesquita
• Intervenção do Docente – Professor Fausto Pinto
• Intervenção do Reitor da Universidade de Lisboa – Professor Luís Ferreira
• Intervenção musical – Coro Infanto-Juvenil da Universidade de Lisboa, dirigido pela Maestrina Erica Mandillo

  17h00 – Encerramento da Cerimónia

Esta sessão está integrada no programa de receção aos novos estudantes da universidade “Bem vindo à ULisboa” que decorre no mesmo dia, na Alameda da Universidade, com atividades desportivas, entrega de kits de boas vindas e uma sunset party.

Hybrid Event under the Auspices of the Czech EU Presidency6th September 2022

FH Europe together with Diagnoza FH, its its Czech member, are proud to announce the upcoming meeting “FH Paediatric screening moving prevention from evidence to action: overcoming the barriers to implementation” on 6 September 2022. The meeting is an accompanying event under the auspices of the Czech Presidency of the EU 2022, which started on July 1, 2022. It will be held in the Czech Senate in Prague between 13:00 and 16:30 CET.

This European event, organized by the FH patient advocacy groups, will convene thought leaders from across different sectors. It will look beyond the technical questions about FH paediatric screening that have dominated the screening debate thus far. International experts will explore specific barriers (science, funding, healthcare systems, behaviour) which are hampering the implementation of screening and how these barriers may be overcome to secure universal implementation of inherited high cholesterol screening – a solution to beating cardiovascular diseases (CVD) and building cardiovascular health (CVH) across Europe.

To ensure that this meeting accelerates action and implementation, an output of the event will be a Prague Declaration – a clear blueprint of what is now needed to overcome barriers and implement FH paediatric screening programmes throughout Europe.

Find out more about FH – an unresolved cardiovascular public health issue …

Prague Declaration

The outcome of this meeting is a political document – the Prague Declaration.

BARCELONA & ONLINE
Friday 26 – Monday 29 August

Annual Conference 2022 – 100 Years

                                    Projeto: Estatística Cardiovascular

Houston Methodist DeBakey Heart & Vascular Center

12 de Janeiro de 2022

II CONGRESSO INTERNACIONAL BRASIL – ALEMANHA DE CARDIOLOGIA

23-25 de Setembro de 2021

15-17 September 2021

digitally through the lens of Lisbon, Portugal

The EHMA Annual Conference is the preeminent European conference on health management. This year, for its 26th edition, EHMA 2021 will be taking place digitally through the lens of Lisbon, Portugal on 15-17 September 2021. We are pleased to be hosted by the Associação Portuguesa de Administradores Hospitalares (APAH).

The EHMA Conference is the place for all healthcare stakeholders to come together, discuss current topics and exchange innovation and best practices. We strive to gather and connect health managers from Europe and beyond to exchange knowledge on excellent delivery of healthcare to ensure the health and well-being of European citizens and communities.

EHMA 2021 will be the place where to present your research and hear from experts on the most contemporary topics on health management including digitalisation, integrated care, sustainable health systems, value-based healthcare, and much more.

For up-to-date information on our Annual Conference, please visit https://ehmaconference.org

Cardiovascular Disease Prevention and Innovation Forum

Waheed Jamal, MD

Published Jul 28, 2021+ Follow

I recently had the pleasure of speaking with Professor Pinto, President of the World Heart Federation as well as Head of Cardiology at the Hospital de Santa Maria in Lisbon, Dean of the Faculty of Medicine of the University of Lisbon, and Past President of the European Society of Cardiology.

 As with most conversations of late it is not surprising COVID-19 was the first topic discussed. COVID-19 has affected each of us in different ways and although undisputedly devastating, we agreed that the medical community has come far and that these advances are here to stay. Professor Pinto said rather poignantly, “in difficult times we should try to transform the negative things and find opportunities to deal with some of the issues we have to face.” One such opportunity is presented by the huge technological developments in ‘telemedicine’.

 Telemedicine or telehealth refers to the delivery of medical services to patients remotely. In the 21st century, the most common methods are via telephone or more advanced digital platforms with live video.

 I agree with Professor Pinto that although these solutions already existed, the pandemicgave us opportunities to rethink some of the models that we are used to. Necessity drove the uptake of digital solutions much more widely and effectively. Continuing to deepen the use of telemedicine will be crucial – we can look to expand its scope to awareness raising and increasing patient access to medical care both during and beyond the pandemic.

 We also discussed multidisciplinary care, a topic close to my heart. Professor Pinto commented “the profile of the patient that we see today is different from the one we used to see 10-20 years ago” – the patients are more complex, with more comorbidities and interactions between different organs or systems. Consequently new “subspecialities” are arising to manage the cardio-renal axis, brain-heart axis and metabolic syndrome, all of which put a higher demand on physicians. Despite the recognised connectivity of health conditions, multidisciplinary cooperation is one of the biggest challenges for the medical community today.

Professor Pinto believes that using multidisciplinary teams and the integration of different specialist fields are essential for good clinical practice, and for the improvement of care of highly comorbid conditions. In order to do this effectively, the organisational structure needs to change to allow these communication silos to be broken down, something the World Heart Federation is actively researching.

 Regarding the longer-term outlook for cardiovascular medicine, I asked what changes he personally hopes to see for patients. Professor Pinto said that in the last 20 years, “the decline in mortality in all the medical cardiac conditions has been huge, but at the same time the prevalence of disease has been increasing.” He believes that the shift in focus needs to be on improving prevention through addressing disease risk factors.

 “80% of CV diseases are preventable, which is amazing…I would love to see in 10 years’ time the reduction in the prevalence of disease.”

 The second big shift Professor Pinto foresees in the next 10 years is an increased personalisation of medicine: “When we treat the patient today, we are not 100% sure what’s going to happen…and that’s something we need to improve”. His view is that the better the knowledge about disease mechanisms, the more accurately and effectively we can diagnose, treat, develop new treatments and prevent diseases.

 Professor Pinto has fantastic insight and understanding into the whole cardiovascular landscape, working in a global capacity leading the World Heart Federation and in his previous role as President of the European Society of Cardiology, and directly with patients from his hospital in Lisbon. As a physician and scientist in the field of cardiovascular medicine, I was looking forward to this discussion and it has confirmed many of my views on the evolution of cardiovascular care.

PROGRAMA

Álvaro Liprandi
– Presidente da Sociedade Inter Americana de Cardiologia
– Chefe de Cardiologia do Sanatorio Güemes. Buenos Aires, Argentina

Carlos Rochitte
– Editor-chefe do ABC Cardiol – Arquivos Brasileiros de Cardiologia e Presidente do DIC-SBC 2020-2021.
– Presidente do DIC-SBC 2020-2021.

Celso Amodeo
– Médico do corpo clínico do Hcor e colaborador do setor de cardiopatia hipertensiva da UNIFESP.
– Presidente da Sociedade Brasileira de Cardiologia

Claudio Tinoco
– Editor chefe do IJCS e Professor Associado da Universidade Federal Fluminense

Evandro Tinoco
– Presidente do Departamento de Insuficiência Cardíaca (DEIC/SBC)
– Coordenador da Universidade do Coração – SBC

Fausto Pinto
– Diretor da Faculdade de Medicina da Universidade de Lisboa
– Presidente, World Heart Federation (WHF) (2021-2022)

Lidia Zytynski
– Pós Doutorado no Brigham and Women’s Hospital – HMS, Boston, MA, US
– Professora Titular da Escola de Medicina/PUCPR

Marcus Simões
– Coordenador da Clínica de Insuficiência Cardíaca e do Centro de Investigação em Amiloidose do HC-FMRP-USP
– Presidente do Grupo de Estudos em Miocardiopatias – GEMIC/DIEC/SBC

Moderação:

Fabiana Marcondes
– Médica assistente do Núcleo de Transplantes do Incor, Universidade de São Paulo
– Diretora Científica do Departamento de Insuficiência Cardíaca – DEIC/SBC 2021/2022

José Albuquerque
– Professor Titular de Cardiologia da Universidade Federal do Maranhão (UFMA)
– Doutor em Cardiologia pela INCOR – Faculdade de Medicina da USP

30 June 2021

Cardiovascular disease (CVD) is the world’s biggest killer, claiming 18.5 million deaths every year. Across the developed and developing world, preventing, and managing heart disease remains a major challenge. More worryingly, the COVID-19 pandemic has made people living with CVD even more vulnerable and has put even more barriers to their access to care. 

Yet, in every crisis there is an opportunity to start afresh with new thinking. Devastating as it has been globally and for people living with CVD, the pandemic made clear the importance of health data in navigating complexity and emergencies. Data does not live in a vacuum, however, nor does it speak for itself. We need skills, understanding, and governance to make it meaningful and impactful for heart health, especially in the post-COVID world when we expect a tsunami of CVD. 

To that end, the World Heart Federation (WHF) is developing the World Heart Observatory as its contribution to the data-driven future of the cardiovascular and wider health community. The Observatory will collate and curate multiple CVD data initiatives, including from WHO, the Global Burden of Disease, and from the WHF national society members, into actionable knowledge for cardiologists, patient organizations, health advocates, researchers, and industry. Its added value lies in identifying gaps and research needs, building capacity in data curation, analysis, and dissemination, and providing a debate forum in relation to global CVD data. The Observatory’s open-access online platform will be launched by the end of 2021.  

Data governance will be at the core of the Observatory’s work, partnerships, and impact. We, therefore, welcome the opportunity to participate in and support WHO’s Health Data Governance Summit as the forum for greater international collaboration on data governance and a platform to encourage consensus around health data as a global public good. 

The World Heart Federation is an umbrella organization, in official relations with the World Health Organization, representing the entire cardiovascular community through its +200 Members in more than 100 countries. Since 2018, WHF has been making digital health and health data one of its key areas of work across its programmes, publications, events, and campaigns. Learn more about WHF and the impact it is making at https://world-heart-federation.org/. 

GOVERNING DATA FOR BETTER HEALTH

Webinar Discussion Guideline

Medical Advancements and Challenges Amidst the COVID-19 Pandemic – Angina

Dates: May 14 -15, 2022 (Saturday & Sunday)

Venue: To be confirmed

The Hong Kong Medical Forum (HKMF) is an annual event organised by the Department of Medicine, School of Clinical Medicine, The University of Hong Kong, Queen Mary Hospital, Hong Kong. The objective of the HKMF is for Continuing Professional Education (CPE) of different disciplines and subspecialties, through state-of-the-art lectures by local and overseas speakers who are distinguished specialists in their respective fields.

The target audience includes general practitioners, family and specialist physicians, clinicians of other specialties, basic and higher physician trainees, nurses, allied health professionals and medical students. An exhibition of medical products will be held concurrently to bridge users and the industry on the latest advances available on the market.

We look forward to bringing a worthwhile meeting for everyone to enjoy.

Organizing Committee

Forum SecretariatHong Kong Medical Forum Secretariat 
University Department of Medicine 
Room 405, Professorial Block 
Queen Mary Hospital 
Pok Fu Lam 
Hong Kong 

Tel: (+852) 2255-6709 
Fax: (+852) 2855-1143 
Email: medconf@hku.hk
Website: https://hkmf.hku.hk/

13 de Maio 2021

13 de Maio de 2021

Cerimónia que marca o início da vida clínica dos estudantes do 4º ano do MIM.

WHF Webinar

11 May 2021

“Rheumatic heart disease has a huge cost to society in poorer regions, as it affects mainly young people. We want everyone to live healthy, productive lives, regardless of where they live. For this to happen, RHD needs to be in the limelight and WHO is fully supportive of WHF’s efforts to achieve its elimination, calling on donors and governments to scale up actions to prevent and manage the disease.” – Dr Tedros, WHO Director-General.

5 May 2021

O Nutri2Go é um congresso pioneiro na área da Nutrição organizado pela Associação de Estudantes da Faculdade de Medicina de Lisboa, contando com a participação de alunos da Licenciatura em Ciências da Nutrição e do Mestrado Integrado em Medicina. Tem como objetivos centrais, por um lado, a promoção do conhecimento na vasta área da Nutrição e, por outro, a oportunidade de adquirir skills de partilha desta informação na comunidade, tendo por base diversas palestras, workshops e formações. Apesar de ser a sua primeira edição, acreditamos veementemente na sua futura imposição como congresso de Nutrição de referência a nível nacional, concretizando uma aposta sem precedentes na formação dos nutricionistas e médicos do futuro e no impacto como agentes ativos de ação na comunidade. 

In CPC2021

Bem-vindos ao CPC 2021!

A preparação do CPC 2021 decorre em franco progresso.
Queremos deixar uma mensagem de esperança e de empenho baseados na vivência de todas as adversidades ocorridas na preparação do CPC 2020 mas que não impediram que fosse conseguido um congresso de elevado nível cientifico. Assim esperamos que todo o empenho e entusiasmo desta comissão organizadora permita manter o CPC no nível de excelência a que sempre nos habituamos.
Assim o CPC 2021 que decorrerá de 30 de Abril a 2 Maio, está a ser estruturado em modo digital/virtual, porque a imprevisível evolução da pandemia Covid não nos permite, por enquanto, ter outras expectativas.
De todo o modo fica a promessa de nos adaptarmos a outros modelos, assim o quadro epidemiológico o permita

The Global Diabetes Compact is a major new WHO initiative which will unite people working in diabetes prevention, treatment and care, including people living with the condition, around a common agenda.

31 March 2021

In addition to the direct health risks of the COVID-19, the indirect effects have also severely disrupted access to basic health services that prevent, diagnose, and treat patients with noncommunicable diseases. Every year, NCDs kill 41 million people — making up 71% of all deaths globally. The majority of these deaths occur in low- and middle-income countries, where health systems often have limited capacity and resources for health and care.

We’re now facing a syndemic — the convergence of several epidemics — with individuals around the globe facing severe disruption to care, preventive screenings, and postponed surgeries. It has also created a ticking time bomb when it comes to cardiovascular health. At the height of the crisis, more than half of the 155 countries surveyed by the World Health Organization reported partially or completely disrupted services for hypertension treatment, with 31% of cardiovascular emergencies disrupted

17-18 March 2021

Ciclo de conferências “A Europa depois da pandemia: como superar a crise, aprofundar o projeto europeu, reconstruir os laços transatlânticos e reforçar a coesão depois da pandemia?”.

Nesta terceira conferência, o painel será dedicado à reflexão sobre os investimentos estratégicos em infraestruturas e na inovação no setor da saúde.

Para obter mais informações sobre o programa e os participantes, por favor visite a página de internet e a página de Facebook da Embaixada de Portugal em Praga.

Organização

Embaixada de Portugal em Praga

Sharing knowledge of renal denervation (RDN) as a new device-based therapy for control of raised blood pressure

February 10, 2021 | What can we expect from cardiology this year? Roxana Mehran gets a preview from Stephan Achenbach, Mitchell Elkind, Fausto Pinto, and Athena Poppas.

On 18 March, the Federation of European Academies of Medicine (FEAM), with support of the Portuguese Academy of Medicine, will organise a digital conference focused on the future of the medical profession, from the training of young professionals to the challenges on the integration of academic medicine in medical practice.

The advancement of digital technologies has contributed greatly in the medical field, but has also posed challenges. If we look at education, few medical courses in Europe changed their curriculum in recent years.

In this conference focused on medical training, Professor Fausto Pinto (Portuguese Academy of Medicine) will look at “the facing change of medicine in the next 10 years”, while Professor Stefan Constantinescu (Royal Academy of Medicine of Belgium and Romanian Academy of Medical Sciences) will dive in into the topic of “the integration of academic medicine in medical practice”.

Looking to a long-term future, we will have an open discussion on “What kind of doctor do we want for the future?” with professors and students from around Europe.

Join this discussion and register at the event, here.

Agenda

09:30: Opening remarks – Professor George Griffin, President of the FEAM; Manuel Heitor, Portuguese Minister of Science, Technology and Higher Education; and Maria do Céu Machado, Vice-president of the FEAM.

09:50: Conference #1: “The facing change of medicine in the next 10 years” – Professor Fausto Pinto, Portuguese Academy of Medicine

10:25: Conference #2: “The integration of academic medicine in medical practice” – Professor Stefan Constantinescu, Royal Academy of Medicine of Belgium and Romanian Academy of Medical Sciences

11:00: Open Discussion: “What kind of doctor do we want for the future?” – President of the Panel: Professor Manuel Sobrinho Simões, Portuguese Academy of Medicine;

Panelists: Professor Jean Sibilia, Dean of the Strasbourg Medical School; Professor Jenny Higham, Principal, St George’s, University of London;

12:00: Closing remarks – Professor George Griffin, President of the FEAM

Angina updates 2021

A SBC, em parceria com a SBC/AM, criou uma campanha solidária para levar assistência médica à população ao estado do Amazona, através da telemedicina durante esse período de crise.

Acompanhe o lançamento ao vivo do evento e saiba como ser um voluntário neste nessa ação que conta com os apoios de: World Heart Federation (WHF), Fundação Adib Jatene, CONASEMS, Conexa Saúde.

Dia 22 de janeiro, às 10h (horário de Brasília) / 9h (horário de Manaus)

Link para evento: http://sosamazonas.cardiol.online/

27 January 2021

Amanhã, pelas 21h, no Grupo do Facebook COVID19 dúvidas respondidas por profissionais de saúde, vai realizar-se um webinar com o Professor Fausto J. Pinto onde o principal objetivo será esclarecer os participantes com informação fidedigna sobre a Covid-19.

Para assistir, terá como primeiro passo pedir para aderir ao grupo no Facebook.

HOSPITAL E ACADEMIA: OLHARES PARA UMA RESPOSTA DE FUTURO

In CHULN “O Hospital de Santa Maria comemora o seu 66.º aniversário no dia 8 de Dezembro e no dia seguinte assinala essa data com as suas instituições irmãs, a Faculdade de Medicina ULisboa e o Instituto de Medicina Molecular, num webinar onde se destaca o papel do Centro Académico de Medicina de Lisboa na resposta à pandemia. Assista à sessão em https://www.apdh.pt/evento/25.”

In APDDH “A APDH realizou o 8.º Congresso Internacional dos Hospitais “Saúde 6.0: Pessoas e Tecnologia”, com o Patrocínio Institucional da Federação Internacional dos Hospitais (IHF) e da Federação Europeia dos Hospitais (HOPE) e a colaboração especial da Altice Portugal,  durante os dias 26 e 27 de novembro de 2020, no Showroom do edifício sede da Altice Portugal, em Lisboa, em formato virtual face ao atual contexto pandémico.

No atual panorama da Saúde em Portugal estes eventos adquirem grande relevância, a nível nacional e internacional, pelo que contamos com a participação de importantes personalidades no Setor, congregando um elevado número de profissionais de Saúde e dirigentes hospitalares de topo.

A APDH decidiu criar paralelamente ao 8º Congresso Internacional dos Hospitais e no contexto de resposta dos sistemas de saúde à Covid-19, um concurso internacional de fotografia que retratasse o impacto da pandemia COVID-19 nos serviços de saúde, nos seus profissionais e utentes.

Idioma do Congresso: Português, à exceção da Sessão de Abertura que teve dois momentos em inglês.”

Sociedade Mexicana de Cardiologia

Iron deficiency is present in one-third of the world’s population, but heart failure patients are disproportionately affected – up to two thirds of people living with chronic heart failure. Join experts explore the link between iron deficiency and heart failure and identify strategies to improve awareness and prevalence of iron deficiency in people living with heart failure.

20,21,22 de Novembro de 2020

19 | 20 | 21 de Novembro de 2020

WEBSITE: https://www.sac.org.ar

Realizado pela Sociedade Brasileira de Cardiologia, o evento acontecerá de 20 a 22 de novembro e promete apresentar os estudos mais importantes publicados sobre a ciência cardiovascular em 2020

Em 2020, o Congresso Brasileiro de Cardiologia será on-line. A Sociedade Brasileira de Cardiologia (SBC) assume o desafio de realizar a 75° edição do evento em um formato digital e interativo. A decisão se baseou na preocupação com a saúde e o bem-estar de todos. O maior encontro da cardiologia brasileira e latino-americana do ano será realizado de 20 a 22 de novembro e promete um momento de atualização científica e profissional, e de união para todos esses especialistas do Brasil.

Esse ano, com a pandemia da Covid-19, tem-se um cenário que alterou a vida dos brasileiros de uma maneira geral e os eventos médicos também sofreram impacto. “O formato do Congresso será digital, mas a qualidade e o compromisso são os mesmos: promover a integração do melhor da ciência cardiovascular com as ideias de diversas correntes do pensamento científico na especialidade para cada cardiologista brasileiro”, destaca o presidente da SBC, Marcelo Queiroga.

75º Congresso Brasileiro de Cardiologia

Data: 20 a 22 de novembro

Inscrições: www.sbc2020.com.br

10 de Novembro de 2020

Esta conferência pretende efetuar um diagnóstico da cidade ao nível das políticas ambientais, avaliar o impacto do ambiente urbano na saúde, no bem-estar da população e na economia da cidade.

São também analisados os efeitos nocivos na saúde induzidos e acelerados por fatores de contaminação ambiental (epidemias e pandemias), procurando reduzir a sua incidência, prevenir novas ameaças e reforçar a ação neste domínio, dando especial atenção aos grupos mais vulneráveis.

A conferência é para cidadãos, profissionais e estudantes dos mais variados setores de atividade que pretendam consolidar os seus conhecimentos sobre os efeitos do ambiente urbano na saúde.

Estima-se que 54% da população mundial vive em áreas urbanas, prevendo-se que em 2050 esta percentagem seja de 66%. Um crescimento exponencial que coloca vários desafios às cidades. 
 

A CCDR LVT – Comissão de Coordenação e Desenvolvimento Regional de Lisboa e Vale do Tejo terá como uma das oradoras na Conferência: Sandra Mesquita | Monitorização e avaliação da qualidade do ar em Lisboa. 

2º Simpósio de Intercâmbio em Medicina -Cooperação de Escolas Médicas de Língua Portuguesa

30 October – 1 November 2020

Congress Link: www.uccvs.org

trata-se de um dos principais eventos do Curso de Medicina da Universidade de Mogi das Cruzes, sendo este, realizado, exclusivamente, por acadêmicos com o apoio da Coordenação do Curso e da Diretoria do Centro de Ciências Biológicas da Universidade de Mogi das Cruzes. Desde sua primeira edição, em 1981, o COMUMC propicia a integração entre os alunos, médicos e pesquisadores de todo país, com a finalidade de aprimorar conhecimentos e promover atualizações sobre as mais diversas áreas da Medicina, por meio de debates, palestras e incentivando a produção científica.

Finding solutions in adverse times

Temática: “Segurança do Profissionais de Saúde: Uma prioridade para a Segurança do Doente”

Virtual Edition – 3, 4, 10 and 11 July 2020

Estágios clínicos suspensos: e agora, 6º ano? Pacientes virtuais substituem pacientes reais? Tele-ensino: porquê só agora? Já agora, COVID-19 e o impacto na PNAFE…Estas são algumas das questões que queremos ver respondidas nesta primeira sessão do TalkMedToMe – COVID-19 Edition.

Webinar da Sociedade Brasileira de cardiologia